These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1490658)

  • 1. Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.
    Silbergeld A; Klinger B; Schwartz H; Laron Z
    Horm Res; 1992; 37(4-5):160-4. PubMed ID: 1490658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.
    Laron Z; Klinger B; Blum WF; Silbergeld A; Ranke MB
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):301-4. PubMed ID: 1373347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism.
    Laron Z; Klinger B; Jensen LT; Erster B
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):145-50. PubMed ID: 1934530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
    Klinger B; Jensen LT; Silbergeld A; Laron Z
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH.
    Laron Z; Klinger B; Silbergeld A; Lewin R; Erster B; Gil-Ad I
    Acta Endocrinol (Copenh); 1990 Sep; 123(3):378-82. PubMed ID: 2239085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects.
    Klinger B; Ionesco A; Anin S; Laron Z
    Acta Endocrinol (Copenh); 1992 Dec; 127(6):515-9. PubMed ID: 1362849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature.
    Laron Z; Suikkari AM; Klinger B; Silbergeld A; Pertzelan A; Seppälä M; Koivisto VA
    Acta Endocrinol (Copenh); 1992 Oct; 127(4):351-8. PubMed ID: 1280392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin responses to hypoglycemia and thyrotropin-releasing hormone in anorexia nervosa.
    Karibe C; Tamai H; Kiyohara K; Kobayashi N; Nakagawa T
    Acta Psychiatr Scand; 1988 Oct; 78(4):442-7. PubMed ID: 3147579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triiodothyronine administration reduces serum growth hormone levels and growth hormone responses to thyrotropin-releasing hormone in patients with anorexia nervosa.
    Valcavi R; Zini M; Portioli I
    Psychoneuroendocrinology; 1990; 15(4):287-95. PubMed ID: 2128417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooled prolactin measurements in the evaluation of short children.
    Shulman DI; Hu CS; Root AW; Bercu BB
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1261-7. PubMed ID: 2511222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of growth hormone, insulin-like growth factor-I and prolactin in normal, growth retarded and anencephalic human fetuses.
    Arosio M; Cortelazzi D; Persani L; Palmieri E; Casati G; Baggiani AM; Gambino G; Beck-Peccoz P
    J Endocrinol Invest; 1995 May; 18(5):346-53. PubMed ID: 7594222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism.
    Laron Z; Klinger B; Erster B; Anin S
    Lancet; 1988 Nov; 2(8621):1170-2. PubMed ID: 2903379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone induces insulin resistance in Laron dwarf cells via lactogenic receptors.
    Geffner ME; Bersch N; Golde DW
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1039-47. PubMed ID: 8473379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.
    Laron Z; Klinger B; Erster B; Silbergeld A
    Acta Endocrinol (Copenh); 1989 Oct; 121(4):603-8. PubMed ID: 2800930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men.
    Hayashi S; Okimura Y; Yagi H; Uchiyama T; Takeshima Y; Shakutsui S; Oohashi S; Bowers CY; Chihara K
    Endocrinol Jpn; 1991 Feb; 38(1):15-21. PubMed ID: 1915110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased growth hormone (GH) response to oral clonidine in endemic cretinism: effect of L-T3 therapy.
    Martins MC; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 1988; 11(7):477-81. PubMed ID: 3139739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome).
    Cotterill AM; Camacho-Hübner C; Holly JM; Savage MO
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):119-22. PubMed ID: 7688671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.